Returning search results with filters:
Remove filter forAudience: Industry
Remove filter forRecall class: Type I
Remove filter forType: Recall Clear all
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 15 of 23 items.
CAYSTON: Vials may be cracked in affected lots
Vials may be cracked in affected lots.
RecallHealth product recall | 2023-03-03
APO-AMITRIPTYLINE 10mg: NDMA Impurity
Affected lot exceeds concentration limit for N-nitrosodimethylamine (NDMA) at the 48-month stability testing timepoint.
RecallHealth product recall | 2023-02-07
Belzer MPS and Belzer UW: Particulate matter
Presence of particulate matter in affected lot.
RecallHealth product recall | 2023-01-18
Allergenic extract non pollens (Peanut allergy): False negative for skin test
Affected lot may result in a false negative for skin test (peanut allergy).
RecallHealth product recall | 2022-12-14
Now Kids Vitamin D-3: Out of Specification
Affected lot contains active ingredient (Cholecalciferol) levels outside of the labelled claim.
RecallHealth product recall | 2022-12-08
DRAXIMAGE MDP: Affected lot may contain particulate matter
Affected lot may contain particulate matter
RecallHealth product recall | 2022-08-30
JAMP ATORVASTATIN CALCIUM: Affected lot may be labelled with the incorrect strength on the label.
Jamp Pharma Corporation is recalling one lot (D10776B) of Jamp-Atorvastatin Calcium after one bottle labelled to contain 10 mg tablets of Jamp-Atorvastatin Calcium was found to contain 40 mg tablets of Jamp-Atorvastatin Calcium. Pharmacists may not…
RecallHealth product recall | 2022-08-29
PMS-Hydromorphone: Affected lot may contain tablets that could potentially lead to overdose
Pharmascience Inc. is recalling one lot of pms-Hydromorphone, 2 mg tablets, (lot 639268) as the bottles may contain hydromorphone tablets of a different strength (8 mg), meaning they contain higher amounts of hydromorphone. Products from the affected lot…
RecallHealth product recall | 2022-08-22
Taro-Zoledronic Acid: The affected lots may contain particulate matter
Taro Pharmaceuticals Inc. is recalling all lots of Taro-Zoledronic acid injection 5mg/100mL (DIN 02415100) because they may contain particulate matter. Zoledronic acid is a prescription drug used to treat and prevent osteoporosis and to treat Paget's…
RecallHealth product recall | 2022-08-10
JAMP-ATORVASTATIN: The affected lot may contain latex.
Jamp Pharma Corporation is recalling one lot (MHC1403A) of Jamp-Atorvastatin 40 mg tablets due to possible contamination with latex pieces during manufacturing. A piece of latex was found in one tablet from the affected lot.…
RecallHealth product recall | 2022-08-08
NORMOSOL-R: Solution bags may be leaking in affected lot.
Solution bags may be leaking in affected lot.
RecallHealth product recall | 2022-08-04
Apo-Acyclovir Tablets: NDMA impurity
Affected lot exceeds concentration limit for N-nitrosodimethylamine (NDMA).
RecallHealth product recall | 2022-07-28
CALCIUM BOROGLUCONATE 23% STERILE INJECTION: Particulate Matter
Affected lot(s) may contain the presence of particulate matter.
RecallHealth product recall | 2022-07-15
Dr. Reddy's Laboratories Canada Inc. recalls a lot of Succinyl Choline Injection USP
The sterility is out of specification in the affected lot (Periodic Media Fill Validation failure).
RecallHealth product recall | 2022-06-30
Produits de Bien-Être Bodispa recalls sexual enhancement products due to the potential presence of undeclared prescription drug ingredients.
The products may contain undeclared ingredients which are listed on the Prescription Drug List.
RecallHealth product recall | 2022-06-21